These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33997320)

  • 21. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.
    Alagappan M; Pollom EL; von Eyben R; Kozak MM; Aggarwal S; Poultsides GA; Koong AC; Chang DT
    Am J Clin Oncol; 2018 Mar; 41(3):242-247. PubMed ID: 26757436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Shaverdian N; Veruttipong D; Wang J; Schaue D; Kupelian P; Lee P
    Clin Lung Cancer; 2016 Jan; 17(1):39-46. PubMed ID: 26372098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Park EY; Kim YS; Choi KH; Song JH; Lee HC; Hong SH; Kang JH
    Radiat Oncol J; 2019 Sep; 37(3):166-175. PubMed ID: 31591864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.
    Wang Z; Zhan P; Lv Y; Shen K; Wei Y; Liu H; Song Y
    Transl Lung Cancer Res; 2019 Jun; 8(3):214-226. PubMed ID: 31367535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients.
    Chen T; Tang M; Zhou Y; Wang Z; Li S; Wang H; Lu Y; Wang J; Shen W
    Front Oncol; 2023; 13():1216852. PubMed ID: 37456254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 28. Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.
    Hu M; Xu Q; Yang S; Han S; Zhu Y; Lin Q; Sun X; Liu H; Xu Y
    Ann Transl Med; 2020 Oct; 8(20):1310. PubMed ID: 33209890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
    Cho JK; Kim MW; Choi IS; Moon UY; Kim MJ; Sohn I; Kim S; Jeong HS
    BMC Cancer; 2018 Oct; 18(1):969. PubMed ID: 30309318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
    Hsiang CW; Huang WY; Yang JF; Shen PC; Dai YH; Wang YF; Lin CS; Chang WC; Lo CH
    J Hepatocell Carcinoma; 2021; 8():1299-1309. PubMed ID: 34765571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer.
    Cannon NA; Meyer J; Iyengar P; Ahn C; Westover KD; Choy H; Timmerman R
    J Thorac Oncol; 2015 Feb; 10(2):280-5. PubMed ID: 25299234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer.
    Li WC; Wang Z; Gao J; Zhou H; Li J; Zhu XX
    Cancer Manag Res; 2021; 13():1887-1896. PubMed ID: 33654433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
    Chan SWS; Smith E; Aggarwal R; Balaratnam K; Chen R; Hueniken K; Fazelzad R; Weiss J; Jiang S; Shepherd FA; Bradbury PA; Sacher AG; Leighl NB; Xu W; Brown MC; Eng L; Liu G
    Clin Lung Cancer; 2021 Sep; 22(5):390-407. PubMed ID: 33582072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.
    Jin F; Han A; Shi F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():6529-6537. PubMed ID: 27799800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
    Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH
    Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total lymphocyte count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer with chemoradiotherapy.
    Song X; Chen D; Yuan M; Wang H; Wang Z
    Cancer Manag Res; 2018; 10():6677-6683. PubMed ID: 30584362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy.
    Minami S; Ihara S; Komuta K
    J Clin Med Res; 2018 Aug; 10(8):657-664. PubMed ID: 29977424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
    Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
    Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
    Wang J; Kalhor N; Hu J; Wang B; Chu H; Zhang B; Guan Y; Wu Y
    PLoS One; 2016; 11(10):e0163397. PubMed ID: 27695079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.